Home Featured Page 266

Featured

Latest

Germany Establishes EU’s First Psilocybin Compassionate Access Program

Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2)

William Leonard Pickard interviews Bryan Hubbard about the new policy frontier of Ibogaine

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice; Makary’s Priority Voucher Pilot Launches, Mentions Innovative PTSD Treatments; HALT Fentanyl Act Could...

Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50%...

IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX...

Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its...

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies...

Can Psilocybin Assisted Psychotherapy Change Attachment Style?

PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and...

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment...

Octarine Bio announces closing of extended seed round financing of $1.2...

1...265266267...293 Page 266 of 293

Germany Establishes EU’s First Psilocybin Compassionate Access Program

Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness,...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Germany Establishes EU’s First Psilocybin Compassionate Access Program

Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness, and Clinical Horizons (Part 2)

William Leonard Pickard interviews Bryan Hubbard about the new policy frontier of Ibogaine

Pα+ Psychedelic Bulletin #204: FDA Keeps GH Research’s 5-MeO-DMT on Ice; Makary’s Priority Voucher Pilot Launches, Mentions Innovative PTSD Treatments; HALT Fentanyl Act Could...

Bright Minds Biosciences (“BMB”) Proprietary 5-HT2C Agonist Shows an Over 50%...

IntelGenx Announces Strategic Partnership with atai Life Sciences and Proposed TSX...

Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its...

Numinus Wellness Inc. Announces $30 Million Bought Deal Public Offering

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Psychedelic Bulletin: Harvard Revisits Psychedelics; MindMed Attracts Strategic Investor; Psychedelics Companies...

Can Psilocybin Assisted Psychotherapy Change Attachment Style?

PTSF50 – Microdosing and the Placebo Effect, with Balázs Szigeti and...

Aion Therapeutic Files 4 New Patent Applications (Including for the Treatment...

Octarine Bio announces closing of extended seed round financing of $1.2...

EDITOR PICKS

Germany Establishes EU’s First Psilocybin Compassionate Access Program

Chad Charles – Integrating 5-MeO-DMT: Therapy, Harm Reduction, and Best Practices

Dispatch: The Neurobiology of Psychedelics Gordon Research Conference — Circuitry, Consciousness,...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY